Showing results (1971-1980 of 2,189) with videos related to
Sort By:
Pageof 219
Lung Cancer (Amsterdam, Netherlands)|May 11, 2010
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancerNagio Takigawa, Katsuyuki Kiura, Katsuyuki Hotta, et al.Genomics|May 15, 1996
Isolation of cDNA and genomic clones of a human Ras-related GTP-binding protein gene and its chromosomal localization to the long arm of chromosome 7, 7q36N Mizuki, M Kimura, S Ohno, et al.The Lancet. Respiratory Medicine|November 10, 2016
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trialKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.Journal of Cardiovascular Computed Tomography|February 15, 2020
Peri-coronary inflammation is associated with findings on coronary computed tomography angiography and fractional flow reserveMasahiro Hoshino, Seokhun Yang, Tomoyo Sugiyama, et al.Journal of the American Heart Association|February 18, 2022
Prognostic Value of Coronary Sinus Flow Quantification by Cardiac Magnetic Resonance Imaging in Patients With Acute Myocardial InfarctionYoshihisa Kanaji, Tomoyo Sugiyama, Masahiro Hoshino, et al.Plos One|May 25, 2023
Relationship of OCT-defined plaque characteristics with CCTA-derived coronary inflammation and CMR-derived global coronary flow reserve in patients with acute coronary syndromeTomoyo Sugiyama, Yoshihisa Kanaji, Masahiro Hoshino, et al.Heart and Vessels|July 9, 2020
Impact of pericoronary adipose tissue inflammation on left ventricular hypertrophy and regional physiological indices in stable coronary artery disease patients with preserved systolic functionHidenori Hirano, Yoshihisa Kanaji, Tomoyo Sugiyama, et al.Respirology Case Reports|June 8, 2026
Marked Respiratory Improvement After ECMO-Supported Exchange From Metallic to Silicone Stent in Tracheobronchial Stenosis due to Tuberculosis: A Case ReportMayu Goda, Yuki Takigawa, Ken Sato, et al.Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404Takashi Ninomiya, Naoyuki Nogami, Toshiyuki Kozuki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JPTomohide Tamura, Katsuyuki Kiura, Takashi Seto, et al.Pageof 219